1,010
Participants
Start Date
September 1, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
February 28, 2029
Ketamine hydrochloride
Sub-dissociative ketamine, IV
Morphine sulphate
Morphine, IV
NewYork Presbyterian Morgan Stanley Children's Hospital, New York
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Nemours Children's Hospital, Wilmington
Arthur M. Blank Hospital, Atlanta
Children's Wisconsin, Milwaukee
Children's Hospital Los Angeles, Los Angeles
UC Davis Children's Hospital, Sacramento
Seattle Children's Hospital, Seattle
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Columbia University
OTHER